实用肝脏病杂志 ›› 2017, Vol. 20 ›› Issue (4): 464-467.doi: 10.3969/j.issn.1672-5069.2017.04.021

• 肝癌 • 上一篇    下一篇

超声造影和微血流成像对不典型肝癌与肝局灶性结节性增生的鉴别诊断价值分析

马进辉   

  1. 810001 西宁市 青海大学附属医院超声诊断科
  • 收稿日期:2016-12-15 出版日期:2017-07-10 发布日期:2017-07-07
  • 作者简介:作者简介:马进辉,男,35岁,大学本科,主治医师。主要研究方向:肝脏常见病及疑难病的超声诊断。E-mail:majinhui876@163.com

Application of ultrasound contrast and micro blood flow imaging in differential diagnosis of atypical primary liver cancer and focal nodular hyperplasia

Ma Jinhui.   

  1. Department of Ultrasound, Affiliated Hospital, Qinghai University,Xining 810001,Qinghai Province,China
  • Received:2016-12-15 Online:2017-07-10 Published:2017-07-07

摘要: 目的 探讨超声造影和微血流成像技术对不典型原发性肝癌(PLC)和肝局灶性结节性增生(FNH)病变的鉴别诊断价值。方法 2014年1月~2015年12月本院收治的不典型PLC患者35例和FNH患者40例,术前行超声造影检查和微血流成像检查,对比分析两种检查方法诊断指标的异同。结果 PLC病灶造影剂到达时间为(4.1±0.7)s,达峰时间为(37.8±11.4)s,分别显著长于FNH组的(2.5±1.0)s和(24.2±9.5)s(P<0.05);PLC组峰值强度为(23.1±5.7)dB,明显低于FNH组的(30.6±4.3)dB(P<0.05);35例不典型PLC患者中,病灶斑块状增强19例,环状增强16例,在40例FNH患者中,病灶动脉相离心性“轮辐状”增强29例,偏心性增强11例,门脉相均为高增强,延迟相高增强15例,等增强22例,低增强3例;在微血流成像检查方面,PLC组动脉最大血流速度(Vmax)为(64.7±3.3)v·cm-1·s-1,显著低于FNH组的(77.8±5.1)v·cm-1·s-1P<0.05),血流阻力指数(RI)为(0.70±0.05),显著高于FNH组的【(0.53±0.03),P<0.05】;在血流信号等级分布方面,不典型PLC组1级3例(8.6%)、2级19例(54.3%)、3级13例(37.1%),FNH组0级33例(82.5%)、1级7例(17.5%),两组差异有统计学意义(P<0.05)。结论 超声造影和微血流成像技术分别能从造影的时相和增强模式及血流动力学特征上正确区分不典型PLC与FNH,具有较好的鉴别诊断价值。

关键词: 不典型原发性肝癌, 肝局灶性结节性增生, 超声造影, 微血流成像, 鉴别诊断

Abstract: Objective To explore the application of ultrasound contrast and micro blood flow imaging in differential diagnosis of atypical primary liver cancer (PLC) and focal nodular hyperplasia (FNH). Methods 35 patients with atypical PLC and 40 with FNH were selected in our hospital between January 2014 and December 2015. All the patients underwent ultrasound contrast and micro blood flow imaging,and the features of PLC and FNH were analyzed and compared. Results The ultrasound contrast showed that the arrive time of contrast agent [(4.1±0.7) s] and the time to peak [(37.8±11.4) s] in the PLC group were significantly longer than those [(2.5±1.0) s and (24.2±9.5) s] in the FNH group,while the peak strength[(23.1±5.7) dB] was obviously lower than [(30.6±4.3) dB] in the FNH group(P<0.05);As showed by the ultrasonogram of liver tumors in enhancement,there were 19 foci being with patchy enhancement and 16 with ring-enhancement in the PLC group,while in the FNH group,there were 29 foci being with annulare enhancement and 11 with eccentric enhancement in arterial phase,40 foci showing hyper-enhancement in portal phase,16 being with hyper-enhancement,22 with same enhancement and 3 with low-enhancement in delayed phase(P<0.05);the results of micro blood flow imaging showed that the maximum artery blood flow velocity (Vmax) was[(64.7±3.3) v·cm-1·s-1] in patients with PLC, obviously lower than[(77.8±5.1) v·cm-1·s-1] in the FNH group,while the resistant index (RI) was [(0.70±0.05)],much higher than [(0.53±0.03)] in the FNH group (P<0.05);There were 3 foci(8.6%) with blood signals of grade 1,19(54.3%) with that of grade 2 and 13(37.1%) with that of grade 3 in the PLC group,while there were 33 foci (82.5%) with blood signals of grade 0 and 7 (17.5%) with that of grade 1 in the FNH group (P<0.05). Conclusion The ultrasound contrast and micro blood flow imaging could distinguish atypical PLC and FNH by the characteristics of time phase,contrast enhancement and the hemodynamic changes.

Key words: Hepatoma, Focal nodular hyperp-lasia, Ultrasound contrast, Micro blood flow imaging, Differential diagnosis